You are here: Industry Insights > Parkinson

News List

Nourianz Approved to Treat 'Off' Episodes in Parkinson Disease drugs
August 29, 2019
Nourianz (istradefylline) tablets have been approved as an add-on treatment to levodopa/carbidopa for adults with Parkinson disease experiencing "off" episodes...
FDA approves new add-on drug to treat Parkinson's disease biospectrumasia
August 28, 2019
Nourianz (istradefylline) tablets as an add-on treatment to levodopa/carbidopa in adult patients with Parkinson's disease (PD) experiencing "off" episodes
FDA Approves Nourianz (istradefylline) as an Add-On Drug to Treat Off Episodes in Adults with Parkinson’s Disease drugs
August 28, 2019
The U.S. Food and Drug Administration today approved Nourianz (istradefylline) tablets as an add-on treatment to levodopa/carbidopa in adult patients with Parkinson’s disease (PD) experiencing "off" episodes.
New trial to evaluate an investigational drug for Parkinson's disease biospectrumasia
August 26, 2019
SEP361-203 study evaluating an investigational medication in people with Parkinson's disease experiencing Hallucinations and Delusions
Vitamin D Tied to Falls, Nonmotor Symptoms in Parkinson Disease drugs
August 12, 2019
In patients with Parkinson disease (PD), vitamin D levels are significantly correlated with falls and some nonmotor symptoms, according to a study published online in Acta Neurologica Scandinavia.
Is Sex Good Medicine for Parkinson's? drugs
July 16, 2019
Can sex help improve the health of a Parkinson's patient?
FDA grants Fast Track Designation to Parkinson’s therapy europeanpharmaceuticalreview
July 12, 2019
PR001 has received Fast Track Designation from the regulatory body for the treatment of Parkinson’s disease.
Sexual Activity May Cut Disability in Men With Early Parkinson Disease drugs
July 09, 2019
Sexual Activity May Cut Disability in Men With Early Parkinson Disease.
APRINOIA Therapeutics awarded grant from The Michael J. Fox Foundation for Parkinson's Research worldpharmanews
May 24, 2019
APRINOIA Therapeutics, a clinical-stage biotechnology company with a pipeline of therapeutics and imaging diagnostics for neurodegenerative diseases, announces today that ...
Bipolar Disorder a Risk Factor for Parkinson's? drugs
May 24, 2019
Struggling with bipolar disorder is hard enough, but now a new study from Taiwan, China suggests these patients are seven times more likely to develop Parkinson's disease.

Previous page 1 2 3 4 5 6 7 8 9 Next page